Medical Breakthroughs Reported by Ivanhoe.com

Neurological Disorders Channel

http://www.ivanhoe.com

Advances in health and medicine.

/scripts/p_search.cfm

Reported February 1, 2013

Amyvid: "Seeing" Alzheimer's For the First Time

HOUSTON, Tex. (Ivanhoe Newswire) -- More than five million Americans are being robbed. They’re memories and function stolen by a thief that affects their brains. Now, a new tool is helping doctors catch it in the act.

Liebe Ostrow Miller doesn’t want us to show you her husband’s face or mention his name. A stranger to us, he’s becoming more of a stranger to her.

“Sometimes I feel like a widow, but with a live husband. His short term memory is totally gone,” Miller told Ivanhoe.

He was neurologist Paul Schulz’s first patient to have the Amyvid test.

“It’s chilling. It puts a chill through you the first time you see this,” Dr. Paul Schulz at Mischer Neuroscience Institute told Ivanhoe. 

It’s the first test to diagnose Alzheimer’s that doesn’t require a brain biopsy or an autopsy. A liquid agent is injected into a patient and binds to amyloid protein in the brain.

“We bring them in they lay in a scanner for ten minutes and you’re done,” Dr. Schulz stated.

The bright yellow near the edge of the brain in the scan shows a large amyloid build up.

“If you have a significant amount of it, that’s pretty specific for Alzheimer’s disease,” Dr. Schulz said.

Dr. Schulz says Amyvid can help catch the disease earlier and get patients on the right drug therapies to help delay symptoms longer.

“Breakthrough is, is not a big enough term for it,” Dr. Schulz explained.

He hoped Liebe’s husband’s scan would be negative.

“I have to tell you my heart sunk,” Dr. Schulz said.

It showed he did have Alzheimer’s.

“It’s hard. It’s sad and it’s lonely,” Miller said.

Liebe says unfortunately her husband is too far along for the Amyvid results to help him find a better treatment. Dr.  Schulz believes Amyvid is by far the most accurate test for screening for Alzheimer’s in the living, but brain biopsies are still the gold standard because they don’t have the potential for a false positive. He says the test could be tricked by someone without cognitive problems who has a lot of amyloid build up. For that reason Schulz only uses Amyvid on patients who have Alzheimer’s symptoms.

More Information

Click here for additional research on Amyvid:  "Seeing" Alzheimer's For the First Time

Click here for Ivanhoe's full-length interview with Dr. Paul Schulz

If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Andrew Mcintosh at amcintosh@ivanhoe.com

 

For a FREE weekly e-mail update of upcoming Medical Breakthroughs from Ivanhoe.com, sign up at /FirstToKnow/.

Advances in health and medicine.
webdoctor@ivanhoe.com
Copyright © 2014 Ivanhoe Broadcast News, Inc.
2745 West Fairbanks Avenue
Winter Park, Florida 32789
(407) 740-0789

P.O. Box 865
Orlando, Florida 32802

We subscribe to the HONcode principles of the Health 
On the Net Foundation. Click here to verify.We subscribe to the
HONcode principles of the
Health On the Net Foundation.
Verify here.